Korean Circ J.  2003 Dec;33(12):1147-1150. 10.4070/kcj.2003.33.12.1147.

A Case of Superimposed Viral Myocarditis in a Patient with Systemic Lupus Erythematosus

Affiliations
  • 1Department of Medicine, Sungkyunkwan University School of Medicine, Seoul, Korea.
  • 2Samsung Medical Center, Cardiac and Vascular Center, Seoul, Korea.

Abstract

Lupus myocarditis is usually treated using immunosuppressive agents, such as high-dose corticosteroids, azathioprine and cyclophosphamide. Viral myocarditis and enteroviruses have been identified as the most common causative agents of myocarditis in lupus patients. Although immunosuppressive therapy has an important role in the treatment of lupus myocarditis, it is not recommended in patients with infectious or post-infectious viral myocarditis, and supportive care is very important in these patients. A 25-year old female patient, with systemic lupus erythematosus, was admitted due to severe dyspnea, and diagnosed as having heart failure. She recovered 7 days after supportive care for heart failure, without Immuno-suppression. Her sera neutralized coxsackievirus B3 (CVB3) in neutralization test, with the horse anti-CVB3 antibody (Ab, ATCC V030-501-560) used as a positive control. The titers for the neutralizing Ab in her sera were 4 times higher than that of the standard control ATCC Ab.

Keyword

Myocarditis; Coxsackievirus; Systemic lupus erythematosus

MeSH Terms

Adrenal Cortex Hormones
Adult
Azathioprine
Cyclophosphamide
Dyspnea
Enterovirus
Female
Heart Failure
Horses
Humans
Immunosuppressive Agents
Lupus Erythematosus, Systemic*
Myocarditis*
Neutralization Tests
Adrenal Cortex Hormones
Azathioprine
Cyclophosphamide
Immunosuppressive Agents
Full Text Links
  • KCJ
Actions
Cited
CITED
export Copy
Close
Share
  • Twitter
  • Facebook
Similar articles
Copyright © 2024 by Korean Association of Medical Journal Editors. All rights reserved.     E-mail: koreamed@kamje.or.kr